Profil
Matthew P.
Ottmer worked as Senior VP-Strategy & Emerging Businesses at Biogen, Inc. from 2014 to 2015, followed by a position as Chief Operating Officer at Momenta Pharmaceuticals, Inc. from 2015 to 2017.
He then became President at Bioverativ Therapeutics, Inc. before serving as Chief Operating Officer at Voyager Therapeutics, Inc. from 2017 to 2020.
Ottmer received his undergraduate degree from the University of Michigan and his MBA from Kellogg School of Management.
Anciens postes connus de Matthew P. Ottmer
| Sociétés | Poste | Fin |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Directeur des opérations | 12/02/2020 |
| MOMENTA PHARMACEUTICALS, INC. | Directeur des opérations | 01/04/2017 |
| BIOGEN INC. | Corporate Officer/Principal | 01/07/2015 |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | President | - |
Formation de Matthew P. Ottmer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
















